Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aerovate Therapeutics, Inc.

9.80
+0.0000
Volume:- -
Turnover:- -
Market Cap:284.05M
PE:-5.76
High:9.80
Open:9.80
Low:9.80
Close:9.80
Loading ...
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 05, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 02, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 01, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 05, 2023

Major Issues Report

8-K - Current report
Mar 29, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 23, 2023

Major Issues Report

8-K - Current report
Dec 15, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 19, 2022

Correspondence

CORRESP [Cover] - Correspondence